Century Therapeutics, Inc.
IPSC
$0.51
-$0.02-3.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.80% | -142.50% | 312.24% | -15.53% | -0.05% |
| Total Depreciation and Amortization | -2.25% | -0.62% | -2.92% | 0.61% | -4.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 165.50% | 35.62% | -76.40% | 223.39% | 889.67% |
| Change in Net Operating Assets | -12.93% | 99.39% | -13,442.37% | 131.39% | -489.20% |
| Cash from Operations | 7.28% | 20.31% | -42.93% | 14.50% | -3.66% |
| Capital Expenditure | 38.49% | 33.26% | -208.44% | -119.15% | 403.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -200.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.32% | 15.67% | -7.72% | -19.79% | 259.95% |
| Cash from Investing | -24.18% | 16.50% | -8.74% | -21.92% | 215.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -99.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | 119.93% | -320.51% | -99.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.46% | 175.26% | -213.70% | -48.11% | 347.61% |